Contrarius Investment Management’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Contrarius Investment Management’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-34,298	Closed	-$1.81M	–	73
2020 Q3	$1.81M	Buy	+34,298	New	+$2.12M	0.16%	60

Other funds holding BSTC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Contrarius Investment Management's BSTC Position: Q4 2020 in Review

Contrarius Investment Management sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 34,298 shares — an estimated $1.81M sold.

Contrarius Investment Management first reported a position in BSTC in Q3 2020 and held it in 1 quarter. The position peaked at $1.81M in Q3 2020. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

Contrarius Investment Management reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
Contrarius Investment Management sold 34,298 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $1.81M.
Contrarius Investment Management first reported a position in BioSpecifics Technologies Corp. in Q3 2020 and held it in 1 quarter.
Contrarius Investment Management's BioSpecifics Technologies Corp. position peaked at $1.81M in Q3 2020.
1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on Contrarius Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.